ABL-specific tyrosine kinase inhibitor imatinib as salvage therapy in a child with Philadelphia chromosome-positive acute mixed lineage leukemia (AMLL).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples